Project description
New microfluidic platform for timely diagnosis of sepsis
Sepsis is a life-threatening condition, affecting 30 million people worldwide each year. It is caused by a catastrophic response of the host immune system to infection, and delay in treatment can result in multiple organ failure and even death. Current clinical approaches to diagnose sepsis in low-complexity healthcare settings for initial patient admittance fail to provide the required high sensitivity and specificity for timely diagnosis. The EU-funded MuMiPOC project aims to develop a portable, low-cost microfluidic platform with the ability to detect sepsis in under one hour and sensitivity and specificity levels above 90 %. The platform will be based on the quantification of several blood rheological parameters that are affected by sepsis onset.
Objective
Sepsis is a life-threatening condition caused by a dysregulated response of the host’s immune system to infection. If not treated immediately, it can result in multiple organ failure and death. According to the World Health Organisation (WHO), sepsis affects approximately 30 million people worldwide every year, leading to potentially 6 million deaths. The main challenges associated with this condition are that it is, on the one hand, challenging to diagnose in its early stages when it is still potentially reversible, and, on the other hand, it is often confused with non-life-threatening diseases such as flu or gastroenteritis. Current clinical approaches to diagnose sepsis in low-complexity healthcare settings (where most patients are admitted at first) fail to provide the required sensitivity and specificity to overcome these challenges. Portable, fast and economical technologies that help to infer sepsis accurately are therefore vital to tackle these challenges.
This project aims to develop a portable, low-cost microfluidic platform which has the capability to detect sepsis under 1 hour and has sensitivity and specificity levels above 90%. This platform is based on the quantification of several blood rheological parameters that are affected by this pathology. Previous research has shown that these parameters have clinical relevance for the early diagnosis of sepsis. The project will be executed in the company Micronit Microtechnologies BV (host institution) located in the Netherlands under the supervision of Dr. Maciej Skolimowski. This project also includes a secondment in the Department of Intensive Care at the Erasme Hospital – Université Libre de Bruxelles (secondment institution) located in Belgium under the supervision of Prof. Jean-Louis Vincent. The duration of the project is 24 months.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences basic medicine immunology
- medical and health sciences basic medicine pathology
- engineering and technology other engineering and technologies microtechnology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2019
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
7521 PV Enschede
Netherlands
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.